Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-29

FDA Approved: LAMOTRIGINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for lamotrigine submitted by Zydus Pharmaceuticals USA Inc. The exact changes covered by the supplement (e.g., labeling …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)